Skip to content
Congenica

Congenica

Biotech·UK·Exited 2025·Held 10yr
Entry
2015
Hold
10yr
Exit
2025

Who owns Congenica?

Congenica was owned by Cambridge Innovation Capital through CIC Fund II (2022 vintage) from 2015 to 2025, exited via Trade Sale. Across its history, Congenica has been through 3 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-07

Cambridge Innovation Capital
Most recent investor
Cambridge Innovation Capital
CIC Fund II · 2022 · VC
3 ownership periods · full history below

Key facts

HQUK
SectorBiotech
StatusAcquired
Key takeaways
  • ·Fully exited in 2025.
  • ·Average hold across 3 realized cycles: 10 years.

Ownership history

3 ownership periods · co-invest detected

Exited
Last exited in 2025 to .
Co-invest · 3 holders · 2014 · 2025
Amadeus Capital Partners
2014 · 2025(11yr) · Amadeus IV Digital Prosperity Fund · 2013 · Growth
Trade Sale · to
MOIC
Cambridge Innovation Capital
2015 · 2025(10yr) · CIC Fund II · 2022 · VC
Trade Sale · to
MOIC
Parkwalk Advisors
2017 · 2025(8yr) · Parkwalk Opportunities EIS Fund · 2009 · VC
Trade Sale · to
MOIC
Track Congenica

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Congenica?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Congenica.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue